| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |